These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2247451)

  • 1. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.
    Swain AL; Miller MM; Green J; Rich DH; Schneider J; Kent SB; Wlodawer A
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8805-9. PubMed ID: 2247451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.
    Jaskólski M; Tomasselli AG; Sawyer TK; Staples DG; Heinrikson RL; Schneider J; Kent SB; Wlodawer A
    Biochemistry; 1991 Feb; 30(6):1600-9. PubMed ID: 1993177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.
    Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A
    Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors.
    Petroková H; Dusková J; Dohnálek J; Skálová T; Vondrácková-Buchtelová E; Soucek M; Konvalinka J; Brynda J; Fábry M; Sedlácek J; Hasek J
    Eur J Biochem; 2004 Nov; 271(22):4451-61. PubMed ID: 15560786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors.
    Johnson EC; Malito E; Shen Y; Pentelute B; Rich D; Florián J; Tang WJ; Kent SB
    J Mol Biol; 2007 Oct; 373(3):573-86. PubMed ID: 17869270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.
    Mulichak AM; Hui JO; Tomasselli AG; Heinrikson RL; Curry KA; Tomich CS; Thaisrivongs S; Sawyer TK; Watenpaugh KD
    J Biol Chem; 1993 Jun; 268(18):13103-9. PubMed ID: 8514751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
    Veerapandian B; Cooper JB; Sali A; Blundell TL
    J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
    Dusková J; Dohnálek J; Skálová T; Petroková H; Vondrácková E; Hradílek M; Konvalinka J; Soucek M; Brynda J; Fábry M; Sedlácek J; Hasek J
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):489-97. PubMed ID: 16627941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative differences in the binding free energies of human immunodeficiency virus 1 protease inhibitors: a thermodynamic cycle-perturbation approach.
    Reddy MR; Viswanadhan VN; Weinstein JN
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10287-91. PubMed ID: 1946447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
    Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
    Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-step binding mechanism for HIV protease inhibitors.
    Furfine ES; D'Souza E; Ingold KJ; Leban JJ; Spector T; Porter DJ
    Biochemistry; 1992 Sep; 31(34):7886-91. PubMed ID: 1510976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.
    Dohnálek J; Hasek J; Dusková J; Petroková H; Hradilek M; Soucek M; Konvalinka J; Brynda J; Sedlácek J; Fábry M
    Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):472-6. PubMed ID: 11223536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
    Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
    Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters.
    Bone R; Sampson NS; Bartlett PA; Agard DA
    Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates. A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor.
    Dohnálek J; Hasek J; Dusková J; Petroková H; Hradilek M; Soucek M; Konvalinka J; Brynda J; Sedlácek J; Fábry M
    J Med Chem; 2002 Mar; 45(7):1432-8. PubMed ID: 11906284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations.
    Murthy KH; Winborne EL; Minnich MD; Culp JS; Debouck C
    J Biol Chem; 1992 Nov; 267(32):22770-8. PubMed ID: 1429626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the structure of chemically synthesized HIV-1 protease complexed with a hexapeptide inhibitor. Part I: Crystallographic refinement of 2 A data.
    Miller M; Geller M; Gribskov M; Kent SB
    Proteins; 1997 Feb; 27(2):184-94. PubMed ID: 9061782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
    Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
    J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.